Stock CNST CONSTELLATION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Constellation Pharmaceuticals, Inc.

Equities

CNST

US2103731061

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CONSTELLATION PHARMACEUTICALS : RBC Capital Downgrades Constellation Pharmaceuticals to Sector Perform From Outperform, Price Target Cut to $34 From $50
MT
CONSTELLATION PHARMACEUTICALS : Jefferies Downgrades Constellation Pharmaceuticals to Hold From Buy, Adjusts Price Target to $34 From $53
MT
CONSTELLATION PHARMACEUTICALS : Truist Securities Downgrades Constellation Pharmaceuticals to Hold From Buy, Adjusts PT to $34 From $50
MT
CONSTELLATION PHARMACEUTICALS : BMO Capital Downgrades Constellation Pharmaceuticals to Market Perform from Outperform, Adjusts Price Target to $34 from $48
MT
CONSTELLATION PHARMACEUTICALS : JPMorgan Downgrades Constellation Pharmaceuticals to Neutral from Overweight, Adjusts Price Target to $34 from $38
MT
CONSTELLATION PHARMACEUTICALS : Baird Downgrades Constellation Pharmaceuticals to Neutral from Outperform, Adjusts Price Target to $34 from $40
MT
CONSTELLATION PHARMACEUTICALS : Cowen Downgrades Constellation Pharmaceuticals to Market Perform From Outperform
MT
CONSTELLATION PHARMACEUTICALS : RBC Adjusts Price Target on Constellation Pharmaceuticals to $50 From $52, Keeps Outperform-Speculative Risk Rating
MT
CONSTELLATION PHARMACEUTICALS : BMO Upgrades Constellation Pharmaceuticals to Outperform From Market Perform, Adjusts Price Target to $50 From $27
MT
CONSTELLATION PHARMACEUTICALS : Oppenheimer Adjusts Constellation Pharmaceuticals PT to $23 From $20, Maintains Perform Rating
MT
Constellation Pharmaceuticals : Soars After Release of Response Rates, Results Consistency in Myelofibrosis Patients
MT
CONSTELLATION PHARMACEUTICALS : RBC Adjusts Constellation Pharmaceuticals' PT to $52 From $50, Maintains Outperform-Speculative Risk Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNST Stock
  4. News Constellation Pharmaceuticals, Inc.
  5. Analyst Reco.